4D Molecular Therapeutics, Inc.
FDMT
$4.22
-$0.06-1.40%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -49.67M | -43.84M | -34.95M | -32.40M | -32.28M |
| Total Depreciation and Amortization | 1.78M | 1.70M | 1.62M | 1.59M | 1.51M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.74M | 4.29M | 3.77M | 5.24M | 5.46M |
| Change in Net Operating Assets | -3.72M | 8.46M | -688.00K | -3.52M | 664.00K |
| Cash from Operations | -45.86M | -29.39M | -30.24M | -29.09M | -24.65M |
| Capital Expenditure | -949.00K | -1.78M | -349.00K | -710.00K | -549.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.01M | 29.08M | -73.19M | -262.55M | -6.13M |
| Cash from Investing | 7.06M | 27.30M | -73.54M | -263.26M | -6.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 601.00K | 568.00K | 17.25M | 318.83M | 4.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 601.00K | 568.00K | 17.25M | 318.83M | 4.76M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.20M | -1.52M | -86.53M | 26.49M | -26.57M |
